The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma

Troppan Katharina T.; Melchardt Thomas; Wenzl Kerstin; Schlick Konstantin; Deutsch Alexander; Bullock Marc D.; Reitz Daniel; Beham-Schmid Christine; Weiss Lukas; Neureiter Daniel; Traenkenschuh Wolfgang; Greil Richard; Neumeister Peter; Egle Alexander; Pichler Martin

首页> 外文期刊>Journal of Clinical Pathology >The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma

【24h】

The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma

机译：弥漫性大B细胞淋巴瘤患者纤维蛋白原血浆水平的临床意义

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Fibrinogen plays a crucial role in the pathophysiology of tumour cell growth, invasion and metastasis. The aim of this study was to evaluate the prognostic significance of pretreatment plasma fibrinogen levels in patients with diffuse large B cell lymphoma (DLBCL)

机译：背景技术纤维蛋白原在肿瘤细胞生长，侵袭和转移的病理生理学中起着至关重要的作用。这项研究的目的是评估弥漫性大B细胞淋巴瘤（DLBCL）患者的治疗前血浆纤维蛋白原水平的预后意义

著录项

来源
《Journal of Clinical Pathology》 |2016年第4期|326-330|共5页
作者
Troppan Katharina T.; Melchardt Thomas; Wenzl Kerstin; Schlick Konstantin; Deutsch Alexander; Bullock Marc D.; Reitz Daniel; Beham-Schmid Christine; Weiss Lukas; Neureiter Daniel; Traenkenschuh Wolfgang; Greil Richard; Neumeister Peter; Egle Alexander; Pichler Martin;
展开▼
作者单位

Med Univ Graz, Dept Internal Med, Div Hematol, Graz, Austria;

Paracelsus Med Univ Salzburg, Med Dept Hematol & Med Oncol Hemostaseol Rheumato, Ctr Oncol, Lab Immunol & Mol Canc Res, Graz, Austria;

Med Univ Graz, Dept Internal Med, Div Hematol, Graz, Austria;

Paracelsus Med Univ Salzburg, Med Dept Hematol & Med Oncol Hemostaseol Rheumato, Ctr Oncol, Lab Immunol & Mol Canc Res, Graz, Austria;

Med Univ Graz, Dept Internal Med, Div Hematol, Graz, Austria;

Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA;

Med Univ Graz, Div Oncol, Dept Internal Med, Graz, Austria;

Med Univ Graz, Inst Pathol, Graz, Austria;

Paracelsus Med Univ Salzburg, Med Dept Hematol & Med Oncol Hemostaseol Rheumato, Ctr Oncol, Lab Immunol & Mol Canc Res, Graz, Austria;

Paracelsus Med Univ Salzburg, Inst Pathol, Salzburg, Austria;

Paracelsus Med Univ Salzburg, Inst Pathol, Salzburg, Austria;

Paracelsus Med Univ Salzburg, Med Dept Hematol & Med Oncol Hemostaseol Rheumato, Ctr Oncol, Lab Immunol & Mol Canc Res, Graz, Austria;

Med Univ Graz, Dept Internal Med, Div Hematol, Graz, Austria;

Paracelsus Med Univ Salzburg, Med Dept Hematol & Med Oncol Hemostaseol Rheumato, Ctr Oncol, Lab Immunol & Mol Canc Res, Graz, Austria;

Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA;

展开▼
收录信息美国《科学引文索引》(SCI);美国《化学文摘》(CA);
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment [J] . Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus . 2014,第7期

机译：血浆纤维蛋白原水平作为新辅助治疗患者食管鳞癌术后复发的预测指标的临床意义
2. Plasma fibrinogen level as possible prognostic biomarker in diffuse large B-cell lymphoma [J] . Shehata Amira Mohamed Foad, Aldesoky Amira I, Gohar Suzy F. Hematology. . 2019,第1期

机译：等离子体纤维蛋白原水平在弥漫性大B细胞淋巴瘤中可能的预后生物标志物
3. Plasma fibrinogen level as possible prognostic biomarker in diffuse large B-cell lymphoma [J] . Amira Mohamed Foad Shehata, Amira I. Aldesoky, Suzy F. Gohar Hematology . 2019,第1期

机译：血浆纤维蛋白原水平在弥漫性大B细胞淋巴瘤中可能的预后生物标志物
4. Clinical significance and expression of microRNA-21 in diffuse large B-cell lymphoma cell lines and serum of patients [C] . CHEN Wei-qun, LU Honf-da, KONG De-yong, 2011 Asia-Pacific Conference of tumor biology and medicine . 2011

机译：患者弥漫性大B细胞淋巴瘤细胞株和血清中microRNA-21的表达及临床意义
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed/paraffin-embedded tissue of patients with diffuse large B-cell lymphoma [O] . HUA ZHONG, LAN XU, JI-HUA ZHONG, -1

机译：弥漫性大B细胞淋巴瘤患者福尔马林固定/石蜡包埋组织中miR-155和miR-146a表达水平的临床和预后意义
7. Plasma fibrinogen level as possible prognostic biomarker in diffuse large B-cell lymphoma [O] . Amira Mohamed Foad Shehata, Amira I. Aldesoky, Suzy F. Gohar 2018

机译：血浆纤维蛋白原水平在弥漫性大B细胞淋巴瘤中可能的预后生物标志物

The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma

摘要

著录项

相似文献

相关主题

期刊订阅